Table 1.

Clinical and pathological characteristics among 86 patients with colorectal cancer liver metastases

Factor		All (n = 86)	Expression of DYRK2		P‐value
			High (n = 45)	Low (n = 41)
Patient characteristics	Age, years	63.6 (39–84)	63.4 (39–84)	63.8 (43–83)
		≥64	27	19	0.976
		<64	18	22
	Gender	Male	32	29	0.969
		Female	13	12
	Past medical history	(−)	16	21	0.143
		(+)	29	20
Primary tumor characteristics	Primary site	Colon	29	25	0.957
		Rectum	16	16
	TNM stage	I, II	15	7	0.084
		III, IV	30	34
Colorectal liver metastases characteristics	Timing of operation	Synchronous	9	12	0.318
		Metachronous	36	29
	Number of liver metastases	Single	25	18	0.280
		Multiple	20	23
	Size of tumor, mm	<50	38	33	0.890
		≥50	7	8
	Liver metastasis grade	A	22	20	0.992
		B, C	23	21
Preoperative liver function	ICG R15, %	≤10	16	16	0.673
		>11	22	18
		Unknown	7	7
Preoperative factors	Serum CEA, ng/mL	<20	24	27	0.288
		≥20	20	14
		Unknown	1	0
	Serum CA19‐9, ng/mL	<37	23	22	0.791
		≥37	20	17
		Unknown	2	2

CA19‐9, carbohydrate antigen 19‐9; CEA, carcinoembryonic antigen; ICG R15, indocyanine green retention at 15 min.